138 related articles for article (PubMed ID: 32397009)
1. Thrombin generation predicts early recurrence in breast cancer patients.
Marchetti M; Giaccherini C; Masci G; Verzeroli C; Russo L; Celio L; Sarmiento R; Gamba S; Tartari CJ; Diani E; Vignoli A; Malighetti P; Spinelli D; Kuderer NM; Nichetti F; Minelli M; Tondini C; Barni S; Giuliani F; Petrelli F; D'Alessio A; Gasparini G; Labianca R; Santoro A; De Braud F; Falanga A;
J Thromb Haemost; 2020 Sep; 18(9):2220-2231. PubMed ID: 32397009
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
Gomez-Rosas P; Pesenti M; Verzeroli C; Giaccherini C; Russo L; Sarmiento R; Masci G; Celio L; Minelli M; Gamba S; Tartari CJ; Tondini C; Giuliani F; Petrelli F; D'Alessio A; Gasparini G; Labianca R; Santoro A; De Braud F; Marchetti M; Falanga A;
TH Open; 2021 Jan; 5(1):e56-e65. PubMed ID: 33585786
[No Abstract] [Full Text] [Related]
3. Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.
Giaccherini C; Marchetti M; Masci G; Verzeroli C; Russo L; Celio L; Sarmiento R; Gamba S; Tartari CJ; Diani E; Vignoli A; Malighetti P; Spinelli D; Tondini C; Barni S; Giuliani F; Petrelli F; D'Alessio A; Gasparini G; De Braud F; Santoro A; Labianca R; Falanga A;
Haematologica; 2020 Jun; 105(6):1704-1711. PubMed ID: 31558668
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study.
Falanga A; Santoro A; Labianca R; De Braud F; Gasparini G; D'Alessio A; Barni S; Iacoviello L;
Thromb Res; 2016 Apr; 140 Suppl 1():S55-9. PubMed ID: 27067979
[TBL] [Abstract][Full Text] [Related]
6. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
7. The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Tajiri W; Ijichi H; Takizawa K; Koi Y; Masuda T; Ueo H; Koga C; Nakamura Y; Taguchi K; Okamoto M; Tokunaga E
Breast Cancer; 2021 Jan; 28(1):67-74. PubMed ID: 32601800
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
9. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
[TBL] [Abstract][Full Text] [Related]
10. PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.
Lænkholm AV; Jensen MB; Eriksen JO; Rasmussen BB; Knoop AS; Buckingham W; Ferree S; Schaper C; Nielsen TO; Haffner T; Kibøl T; Møller Talman ML; Bak Jylling AM; Tabor TP; Ejlertsen B
J Clin Oncol; 2018 Mar; 36(8):735-740. PubMed ID: 29369732
[TBL] [Abstract][Full Text] [Related]
11. Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy.
Zhao X; Tang Y; Wang S; Yang Y; Fang H; Wang J; Jing H; Zhang J; Sun G; Chen S; Jin J; Song Y; Liu Y; Chen B; Qi S; Li N; Tang Y; Lu N; Ren H; Li Y
Radiat Oncol; 2020 Sep; 15(1):212. PubMed ID: 32887640
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
Shaker H; Bundred NJ; Landberg G; Pritchard SA; Albadry H; Nicholson SL; Harries LJ; Heah JYE; Castle J; Kirwan CC
Cancer Med; 2020 Mar; 9(5):1768-1778. PubMed ID: 31962001
[TBL] [Abstract][Full Text] [Related]
15. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
16. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
[TBL] [Abstract][Full Text] [Related]
17. Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.
Giaccherini C; Verzeroli C; Russo L; Gamba S; Tartari CJ; Bolognini S; Schieppati F; Ticozzi C; Sarmiento R; Celio L; Masci G; Tondini C; Petrelli F; Giuliani F; D'Alessio A; De Braud F; Santoro A; Labianca R; Gasparini G; Marchetti M; Falanga A;
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139507
[TBL] [Abstract][Full Text] [Related]
18. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2
Hu Y; Wang S; Ding N; Li N; Huang J; Xiao Z
Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
20. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
